Preclinical anti-tumour activity of various intraperitoneal cytostatics in vivo (mouse model) for the treatment of ovarian cancer

被引：0
|
作者：
Dowaji, J.
Donner, A.
Breidenbach, M.
Rath, W.
机构：
[1] Univ Klinikum Aachen, Gynakol & Geburtshilfe, Aachen, Germany
[2] Univ Klinikum Aachen, Inst Pathol, Aachen, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2007年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [21] Generation of a syngeneic mouse model to study the intraperitoneal dissemination of ovarian cancer with in vivo luciferase imaging
    Toyoshima, Masafumi
    Tanaka, Yoshinori
    Matumoto, Mitsuyo
    Yamazaki, Miyuki
    Nagase, Satoru
    Sugamura, Kazuo
    Yaegashi, Nobuo
    LUMINESCENCE, 2009, 24 (05) : 324 - 331
  • [22] In vivo anti-tumour activity and preclinical development of spacer-linked anthraquinonyl-amino acid topoisomerase inhibitors.
    Mincher, DJ
    Turnbull, A
    Bibby, MC
    Double, JA
    Gilmour, PS
    Lowe, G
    Kay, G
    Hickson, ID
    BRITISH JOURNAL OF CANCER, 1999, 80 : 50 - 50
  • [23] Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
    L Qiu
    M J Kelso
    C Hansen
    M L West
    D P Fairlie
    P G Parsons
    British Journal of Cancer, 1999, 80 : 1252 - 1258
  • [24] Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
    Qiu, L
    Kelso, MJ
    Hansen, C
    West, ML
    Fairlie, DP
    Parsons, PG
    BRITISH JOURNAL OF CANCER, 1999, 80 (08) : 1252 - 1258
  • [25] IN VIVO ANTI-TUMOUR ACTIVITY OF ETHYL HEPTYLOXYACETATE AGAINST EHRLICH ASCITES CELLS
    TOWNSEND, GF
    FELAUER, EE
    BROWN, WH
    NATURE, 1963, 198 (487) : 384 - &
  • [26] Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model
    Heravi, Mitra
    Tomic, Nada
    Liang, LiHeng
    Devic, Slobodan
    Holmes, Joseph
    Deblois, Francois
    Radzioch, Danuta
    Muanza, Thierry
    ANTI-CANCER DRUGS, 2012, 23 (05) : 525 - 533
  • [27] Whole cell ELISA for measuring anti-tumour effects of immunotherapies in a mouse tumour model of ALCL
    Carstens, M
    Bittner, C
    Krokowski, M
    Hadlak, M
    Feller, AC
    Merz, H
    IN VIVO, 2003, 17 (04): : 359 - 363
  • [28] Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer
    Hahne, Jens C.
    Kurz, Antje
    Meyer, Susanne R.
    Dietl, Johannes
    Engel, Jorg B.
    Honig, Arnd
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 291 (01) : 131 - 141
  • [29] Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer
    Jens C. Hahne
    Antje Kurz
    Susanne R. Meyer
    Johannes Dietl
    Jörg B. Engel
    Arnd Honig
    Archives of Gynecology and Obstetrics, 2015, 291 : 131 - 141
  • [30] Development of a preclinical serous ovarian cancer mouse model
    Bae-Jump, V.
    Yin, C.
    Zong, X.
    Van Dyke, T.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S20 - S20
12345